If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Three studies presented today at the Society of NeuroInterventional Surgery’s (SNIS) 22nd Annual Meeting discussed whether ...

Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Semaglutide, also known by the brand names Ozempic and Wegovy, is quickly becoming a popular weight-loss medication. (Getty Images) Like nearly 50% of Americans, Talia (not her real name) had ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

How to continue losing weight on semaglutide. While there isn't a set time limit after which semaglutide automatically becomes less effective, your body's response to the drug depends on the rest ...

Semaglutide, a weight-loss drug, showed promise for treating obesity in recent research. Demand quickly exceeded supply after the FDA in June approved once-weekly semaglutide injections.

Myth 6: Semaglutide is a permanent solution to weight loss. Many believe that once they start semaglutide, they’ll be set for life. Unfortunately, that’s not the case.

Semaglutide's Weight-Loss Benefit Also Seen in Patients on Antidepressants — Those on antidepressants lost an average 11% to 19% of body weight across the four STEP trials.